Cognitive dysfunction is a recognized feature of mood disorders, including major depressive
disorder (MDD) and bipolar disorder (BD). Cognitive impairment is associated with poor …

Impairment of cognitive processes is a devastating outcome of many diseases, injuries, and
drugs affecting the central nervous system (CNS). Most often, very little can be done by …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Background Neurocognitive impairment in remitted patients with bipolar disorder contributes
to functional disabilities. However, the pattern and impact of these deficits are unclear …

Background Cognitive impairments are an emerging treatment target in mood disorders, but
currently there are no evidence‐based pro‐cognitive treatments indicated for patients in …

Background There is a paucity of treatments that are capable of reliably and robustly
improving cognitive function in adults with mood disorders. Glucagon-like peptide-1 is …

Objective Cognitive reserve (CR) is a concept that was postulated as a protective factor for
some clinical symptoms after the observation that there is not a direct relationship between …

Background Patients with unipolar disorder (UD) commonly experience cognitive
dysfunction during symptomatic and remitted phases. However, it is not necessarily the …

Background Discrepancies between bipolar patients' reports and neuropsychological testing
have been described and replicated. Unfortunately, no valid, specific, user-friendly, brief …

Background Uncertainty exists regarding the prevalence and clinical features associated
with the practice of polypharmacy in bipolar disorder (BD), warranting a systematic review …